Pharma player Biocon’s Q3FY14 net profit stood at Rs 105 crore surpassing CNBC-TV18 poll estimate of Rs 92 crore, on a year-on-year basis (Y-o-Y). Its net sales stood at Rs 700 crore versus Rs 635 crore (Y-o-Y). The company said that its Malaysian facility is on track for commissioning in FY15.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
